LungLife AI
Company Profile
Company website
Sector
Pharmaceuticals and Biotechnology (Biotechnology)
Description
LungLife is a developer of clinical diagnostic solutions for lung cancer enhanced by artificial intelligence. The Company’s core technologies are integrated in the LungLB® test, which is intended to be used as a tool to provide physicians with additional information to help in the decision-making process for people with indeterminate lung nodules that may be lung cancer following a CT scan.
Investor Access
Event information
There is no Investor Access event planned at the moment - click on "Register your Interest" and we'll tell the Company that you'd like to attend one in the future and update you when an event is planned.
Venue
Time
Financial Calendar
| Event | Date |
| Year End | 31 December |
| Half Year End | 30 June |
| Preliminary Results* | September |
| Interim Results* | March |
| AGM* | May |
* Months based on previous announcements of this kind
